Genomic Confidence

Some oncologists are rather gung-ho about using multiplex genomic tests and ready to use them to evaluate tumors and develop treatments for most of their patients, but others are much more wary about these gadgets, a new study finds.

The survey results, published in the Journal of Clinical Oncology, suggests there is "wide variation" in attitudes among cancer doctors about using multiplex tests to hunt for hundreds of variations in tumors.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.